Anticancer and antibacterial potentials induced post short-term exposure to electromagnetic field and silver

Aly Fahmy Mohamed1, Mohamed Nasr2, Mohamed E Amer3

  • 1International Center for Training and Advanced Researches (ICTAR-Egypt), Cairo, Egypt.

Abstract

Insights

Extremely low frequency electromagnetic field (ELF-EMF) and silver nanoparticles (AgNPs) show potent antibacterial and anticancer effects. Combining ELF-EMF and AgNPs enhances bacterial inhibition and induces cancer cell apoptosis, offering novel therapeutic strategies.

Area of Science:

  • Biophysics
  • Nanotechnology
  • Oncology

Background:

  • Antibiotic and anticancer resistance poses a significant global health challenge, especially for immunocompromised cancer patients.
  • Investigating novel therapeutic modalities is crucial to combat these resistant infections and cancers.

Purpose of the Study:

  • To evaluate the antibacterial and anticancer properties of extremely low frequency electromagnetic field (ELF-EMF) and silver nanoparticles (AgNPs).
  • To assess the synergistic effects of combined ELF-EMF and AgNPs exposure on bacterial viability and cancer cell apoptosis.

Main Methods:

  • Antibacterial activity assessed by bacterial viable count reduction percentage.
  • Anticancer effects evaluated through apoptosis induction in MCF-7 breast cancer cells using flow cytometry (Annexin V/PI staining, cell cycle analysis).
  • Oxidative stress and molecular profiles investigated.

Main Results:

  • Combined ELF-EMF and AgNPs achieved 100% inhibition of K. pneumonia within 2 hours.
  • Synergistic increase in apoptosis in MCF-7 cells observed, with elevated Pre G1 phase cells.
  • Differential cell cycle arrest (S phase for AgNPs, G2/M for ELF-EMF) and modulation of key genes (p53, iNOS, NF-kB, Bcl-2, miRNA-125b) detected.

Conclusions:

  • ELF-EMF and AgNPs exhibit significant antibacterial and anticancer potential, likely mediated by induced oxidative stress.
  • The combination therapy demonstrates enhanced efficacy, suggesting potential as novel agents for infection control and cancer treatment.